SCAS-BTT Bioanalysis Co., Ltd. (called SBB) was established on May 2, 2011 in Korea by Sumika Chemical Analysis Services, Ltd (SCAS, headquarter at Osaka, Japan, President: Nakacheuka Iwao) and Biotoxtech Co., Ltd. (BTT, headquarter at Ochang, Korea, CEO : Jong Koo Kang). SCAS has performed a bio analysis business of nonclinical and clinical research for a long time and BTT is top class nonclinical CRO in Korea. SBB provides the overall service of drug development which called total comprehensive research support as a specialized institution. Also we earned GLP certification of TK and Approval of qualified bioequivalence testing institution by KFDA. SBB provides the high quality Pharmacokinetics (PK) analysis service for the clinical studies in Korea, Japan, and other areas of Asia with advanced technical cooperation with SCAS. And we conduct PK and TK in nonclinical study with Biotoxtech.
